Skip to main content

Table 3 Unadjusted and adjusted odds ratio (OR) of characteristics independently associated with current use of highly effective contraception among HIV-positive respondents receiving antiretroviral therapy (ART) at 18 public sector clinic in Lusaka, Zambia (n = 4691)

From: Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey

 

Women

Men

n = 1206

n = 295

Predictors

Unadjusted OR

Adjusted ORa

Unadjusted OR

Adjusted ORa

(95 % CI)

(95 % CI)

(95 % CI)

(95 % CI)

Age (years)

    

 15–24

ref

ref

b

 

 25–34

1.25 (0.99–1.57)

0.92 (0.63–1.35)

0.97 (0.72–1.31)

 

 35–49c

0.78 (0.59–1.04)

0.57 (0.38–0.87)

ref

 

  > 49

  

0.48 (0.29–0.80)

 

Desire a child in the next year

    

 Yes

ref

ref

ref

ref

 No/Don’t know

1.60 (1.25–2.06)*

2.28 (1.74–2.99)*

2.20 (1.65–2.94)*

2.89 (1.99–4.19)*

HIV status disclosed to partner

    

 No/don’t know/no partner

ref

ref

ref

ref

 Yes

4.39 (3.32–5.80)*

2.32 (1.65–3.26)*

7.93 (2.87–21.95)*

7.32 (2.12–25.25)*

Partner’s HIV status

    

 Negative/Don’t know/No partner

ref

ref

ref

 

 Positive

2.36 (2.05–2.71)*

1.44 (1.16–1.80)*

1.81 (1.33–2.46)

 

Sexually active in previous 6 months

    

 No

ref

ref

ref

ref

 Yes

3.19 (2.72–3.74)*

2.07 (1.62–2.65)*

2.14 (1.45–3.17)*

1.60 (0.95–2.70)

  1. Highly effective modern contraception includes oral contraceptive pills, injectables, sub-dermal implant, intrauterine device, and sterilization
  2. aThe estimation method was backward-selection multivariable logistic model (cluster standard error) with removal probability being ≥ 0.2
  3. bNo man aged 15–24 years used highly effective modern method
  4. cUsed as reference for men because 15–24 age category had no man using dual methods, making the age category highly unstable for referent
  5. * P-value < 0.01